New inhaled drug RB042 enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage study is testing an inhaled drug called RB042 for the first time in humans. Researchers want to see if it is safe and how the body handles it. The study includes 90 healthy adults, some of whom are smokers. Participants will receive either RB042 or a placebo thro…
Phase: PHASE1 • Sponsor: Atisama Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC